Tricyclic steroid hormone nuclear receptor modulators
US7411072B2 · kind B2 · utility
4Cited by
14References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 13, 2003 |
| Grant date | Aug 12, 2008 |
| Priority date | — |
| Expiry date | Nov 15, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/86
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to methods of treating pathological disorders susceptible to steroid hormone nuclear receptor modulation comprising administering to a patient in need thereof an effective amount of a compound of the formula:or a pharmaceutically acceptable salt thereof. In addition, the present invention provides novel pharmaceutical compounds of Formula I, including the pharmaceutically acceptable salts thereof, as well as pharmaceutical compositions which comprise as an active ingredient a compound of Formula I.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.